Research / AVGO / Fundamental state Inspectable configuration
State dimensions Filing 0001730168-25-000098 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
393.87% · OPTIONAL · VALID
Capex intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.89% · OPTIONAL · VALID
Operating cash generation 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
44.92% · OPTIONAL · VALID
Revenue growth 65th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
22.03% · CORE · VALID
Inventory pressure 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
13.67% · OPTIONAL · VALID
Gross margin 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
67.09% · CORE · VALID
Operating margin 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
36.90% · CORE · VALID
R&D intensity 80th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
19.12% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
14.56% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 9/9 normalized Level 3 Jan 30, 2022 9/9 normalized Level 3 May 1, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 30, 2022 9/9 normalized Level 3 Jan 29, 2023 9/9 normalized Level 3 Apr 30, 2023 9/9 normalized Level 3 Jul 30, 2023 9/9 normalized Level 3 Oct 29, 2023 9/9 normalized Level 3 Feb 4, 2024 9/9 normalized Level 3 May 5, 2024 9/9 normalized Level 3 Aug 4, 2024 9/9 normalized Level 3 Nov 3, 2024 9/9 normalized Level 3 Feb 2, 2025 9/9 normalized Level 3 May 4, 2025 9/9 normalized Level 3 Aug 3, 2025 9/9 normalized Level 3 Nov 2, 2025 9/9 normalized Level 3 Feb 1, 2026 9/9 normalized Level 3 May 3, 2026 9/9 normalized Level 3 Aug 2, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 411.56%
Current 393.87%
Delta -17.69% Capex Intensity Decreased
Previous 0.96%
Current 0.89%
Delta -0.07% Cash Generation Increased
Previous 43.69%
Current 44.92%
Delta 1.23% Growth Increased
Previous 20.16%
Current 22.03%
Delta 1.87% Inventory Pressure Increased
Previous 13.44%
Current 13.67%
Delta 0.22% Margin Decreased
Previous 67.96%
Current 67.09%
Delta -0.87% Profitability Decreased
Previous 38.85%
Current 36.90%
Delta -1.95% R And D Intensity Increased
Previous 17.95%
Current 19.12%
Delta 1.17% Sbc Intensity Increased
Previous 11.80%
Current 14.56%
Delta 2.75% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.